Staff Report
Published April 16, 2012

Charleston-based Revolutions Medical Corp. inked a marketing and distribution agreement with Sungwon Medical Co. Ltd. for about 6 million syringes.

Previous coverage: Revolutions Medical receives second large purchase order Revolutions Medical receives 480K-unit international purchase order Revolutions Medical inks marketing agreement abroad Revolutions Medical signs agreement with Chinese manufacturer Mount Pleasant biotech company secures $10 million in financing

Sungwon is a medical equipment and device distribution company located in Cheongju City, South Korea. The agreement grants Sungwon exclusive distribution rights for Revolution Medical’s RevVac safety syringe in South Korea.

Sungwon’s agreement means a minimum order of 1.5 million syringes each quarter. Revolutions Medical and Sungwon are currently working to get the syringe registered under the South Korean Food and Drug Administration.

So far, Sungwon has placed an order to be used for initial marketing in the country.

“We have many good relationships with doctors and hospitals in South Korea and feel confident they will be impressed by the RevVac auto-retractable vacuum safety syringe,” said David Hee Lee, managing director of Sungwon Medical.